Posted December 28, 2020 by akceacanada
Results from the ongoing, (OLE) study of the pivotal NEURO-TTR trial published in the European Journal of Neurology show that patients treated with TEGSEDI® (inotersen) experience.
Contact Email | [email protected] |
Issued By | Akcea Therapeutics Inc. Canada |
Phone | (617) 207-0202 |
Business Address | 1220-55 Metcalfe St., Ottawa, ON K1P 6L5 |
Country | Canada |
Categories | Medical |
Tags | hattr treatment canada , hattr tretament testing , tegsedi , tegsedi testing |
Last Updated | December 28, 2020 |